Reducing the Risk of Viral Infection in Renal Transplantation

Transplantation Proceedings

Volumn 40, Issue 10 SUPPL., 2008, Pages

  Tibbles, L A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; CYCLOSPORIN; FOSCARNET; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; RAPAMYCIN; TACROLIMUS;

ARTICLE; BK VIRUS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK REDUCTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; URINALYSIS; VIREMIA; VIRUS INFECTION; VIRUS INHIBITION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BK VIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; KIDNEY TRANSPLANTATION; POLYOMAVIRUS INFECTIONS; POSTOPERATIVE COMPLICATIONS; TUMOR VIRUS INFECTIONS;

EID: 57649091647     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.10.001     Document Type: Article

References (53)

1. Egli A., Binggeli S., Bodaghi S., et al. Cytomegalovirus and polyomavirus BK posttransplant. Nephrol Dial Transplant 22 suppl 8 (2007) viii72
2. Yu Y., and Alwine J.C. Human cytomegalovirus major immediate-early proteins and simian virus 40 large T antigen can inhibit apoptosis through activation of the phosphatidylinositide 3′-OH kinase pathway and the cellular kinase Akt. J Virol 76 (2002) 3731
3. Humar A., Kumar D., Gray M., et al. A prospective assessment of cytomegalovirus immune evasion gene transcription profiles in transplant patients with cytomegalovirus infection. Transplantation 83 (2007) 1200
4. Cervera C., Filella X., Linares L., et al. TH1/TH2 cytokine release pattern during in vivo cytomegalovirus disease in solid organ transplantation. Transplant Proc 39 (2007) 2233
5. Legendre C., and Pascual M. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: late-onset disease and indirect consequences. Clin Infect Dis 46 (2008) 732
6. Kotenko S.V., Saccani S., Izotova L.S., et al. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc Natl Acad Sci U S A 97 (2000) 1695
7. Krogerus L., Soots A., Loginov R., et al. CMV increases tubular apoptosis through the TNF-alpha-TNF-R1 pathway in a rat model of chronic renal allograft rejection. Transpl Immunol 18 (2008) 232
8. Manuel O., Venetz J.P., Fellay J., et al. Efficacy and safety of universal valganciclovir prophylaxis combined with a tacrolimus/mycophenolate-based regimen in kidney transplantation. Swiss Med Wkly 137 (2007) 669
9. Reinke P., Prosch S., Kern F., et al. Mechanisms of human cytomegalovirus (HCMV) (re)activation and its impact on organ transplant patients. Transpl Infect Dis 1 (1999) 157
10. Bunde T., Kirchner A., Hoffmeister B., et al. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 201 (2005) 1031
11. Motta V.N., and Martins S.L. Impairment of cytomegalovirus-specific cellular immune response as a risk factor for cytomegalovirus disease in transplant recipients. Braz J Med Biol Res 41 (2008) 5
12. Ozaki K.S., Camara N.O., Galante N.Z., et al. Decreased cytomegalovirus infection after antilymphocyte therapy in sirolimus-treated renal transplant patients. Int Immunopharmacol 5 (2005) 103
13. Ozaki K.S., Camara N.O., Nogueira E., et al. The use of sirolimus in ganciclovir-resistant cytomegalovirus infections in renal transplant recipients. Clin Transplant 21 (2007) 675
14. Pang X.L., Doucette K., LeBlanc B., et al. Monitoring of polyomavirus BK virus viruria and viremia in renal allograft recipients by use of a quantitative real-time PCR assay: one-year prospective study. J Clin Microbiol 45 (2007) 3568
15. Giraldi C., Noto A., Tenuta R., et al. Prospective study of BKV nephropathy in 117 renal transplant recipients. New Microbiol 30 (2007) 127
16. Hirsch H.H., Knowles W., Dickenmann M., et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 347 (2002) 488
17. Viscount H.B., Eid A.J., Espy M.J., et al. Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation 84 (2007) 340
18. Ginevri F., Azzi A., Hirsch H.H., et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 7 (2007) 2727
19. Dall A., and Hariharan S. BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol 3 suppl 2 (2008) S68
20. Smith J.M., Dharnidharka V.R., Talley L., et al. BK virus nephropathy in pediatric renal transplant recipients: an analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol 2 (2007) 1037
21. Schwartz J.J., Ishitani M.B., Weckwerth J., et al. Decreased incidence of acute rejection in adolescent kidney transplant recipients using antithymocyte induction and triple immunosuppression. Transplantation 84 (2007) 715
22. Nickeleit V., and Mihatsch M.J. Polyomavirus nephropathy in native kidneys and renal allografts: an update on an escalating threat. Transpl Int 19 (2006) 960
23. Prosser S.E., Orentas R.J., Jurgens L., et al. Recovery of BK virus large T-antigen-specific cellular immune response correlates with resolution of BK virus nephritis. Transplantation 85 (2008) 185
24. Drachenberg C.B., Papadimitriou J.C., and Ramos E. Histologic versus molecular diagnosis of BK polyomavirus-associated nephropathy: a shifting paradigm?. Clin J Am Soc Nephrol 1 (2006) 374
25. Nickeleit V., Singh H.K., and Mihatsch M.J. Latent and productive polyomavirus infections of renal allografts: morphological, clinical, and pathophysiological aspects. Adv Exp Med Biol 577 (2006) 190
26. Drachenberg C.B., and Papadimitriou J.C. Polyomavirus-associated nephropathy: update in diagnosis. Transpl Infect Dis 8 (2006) 68
27. Singh H.K., Bubendorf L., Mihatsch M.J., et al. Urine cytology findings of polyomavirus infections. Adv Exp Med Biol 577 (2006) 201
28. Ding R., Medeiros M., Dadhania D., et al. Noninvasive diagnosis of BK virus nephritis by measurement of messenger RNA for BK virus VP1 in urine. Transplantation 74 (2002) 987
29. Latif S., Zaman F., Veeramachaneni R., et al. BK polyomavirus in renal transplants: role of electron microscopy and immunostaining in detecting early infection. Ultrastruct Pathol 31 (2007) 199
30. Brennan D.C., Agha I., Bohl D.L., et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 5 (2005) 582
31. Shi Y., Moriyama T., Namba Y., et al. Association of treatment with 15-deoxyspergualin and BK virus nephropathy in kidney allograft recipients. Clin Transplant 21 (2007) 502
32. Zhou W., Sharma M., Martinez J., et al. Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults. Viral Immunol 20 (2007) 379
33. Benavides C.A., Pollard V.B., Mauiyyedi S., et al. BK virus-associated nephropathy in sirolimus-treated renal transplant patients: incidence, course, and clinical outcomes. Transplantation 84 (2007) 83
34. Beimler J., Sommerer C., and Zeier M. The influence of immunosuppression on the development of BK virus nephropathy-does it matter?. Nephrol Dial Transplant 22 suppl 8 (2007) viii66
35. Acott P.D. Polyoma virus in pediatric renal transplantation. Pediatr Transplant 10 (2006) 856
36. Batal I., Zeevi A., Heider A., et al. Measurements of global cell-mediated immunity in renal transplant recipients with BK virus reactivation. Am J Clin Pathol 129 (2008) 587
37. Mannon R.B., Hoffmann S.C., Kampen R.L., et al. Molecular evaluation of BK polyomavirus nephropathy. Am J Transplant 5 (2005) 2883
38. Farasati N.A., Shapiro R., Vats A., et al. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 79 (2005) 116
39. Randhawa P., and Brennan D.C. BK virus infection in transplant recipients: an overview and update. Am J Transplant 6 (2006) 2000
40. McCabe M.T., Low J.A., Imperiale M.J., et al. Human polyomavirus BKV transcriptionally activates DNA methyltransferase 1 through the pRb/E2F pathway. Oncogene 25 (2006) 2727
41. Felsani A., Mileo A.M., and Paggi M.G. Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. Oncogene 25 (2006) 5277
42. Weinreb D.B., Desman G.T., Burstein D.E., et al. Expression of p53 in virally infected tubular cells in renal transplant patients with polyomavirus nephropathy. Hum Pathol 37 (2006) 684
43. Lilyestrom W., Klein M.G., Zhang R., et al. Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor. Genes Dev 20 (2006) 2373
44. Fradet-Turcotte A., Vincent C., Joubert S., et al. Quantitative analysis of the binding of simian virus 40 large T antigen to DNA. J Virol 81 (2007) 9162
45. Yu Y., and Alwine J.C. Interaction between simian virus 40 large T antigen and insulin receptor substrate 1 is disrupted by the K1 mutation, resulting in the loss of large T antigen-mediated phosphorylation of Akt. J Virol 82 (2008) 4521
46. Wullschleger S., Loewith R., and Hall M.N. TOR signaling in growth and metabolism. Cell 124 (2006) 471
47. Crespo J.L., and Hall M.N. Elucidating TOR signaling and rapamycin action: lessons from Saccharomyces cerevisiae. Microbiol Mol Biol Rev 66 (2002) 579
48. Jacinto E., and Hall M.N. Tor signalling in bugs, brain and brawn. Nat Rev Mol Cell Biol 4 (2003) 117
49. Hahn W.C., Dessain S.K., Brooks M.W., et al. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 22 (2002) 2111
50. Rodriguez-Viciana P., Collins C., and Fried M. Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control. Proc Natl Acad Sci U S A 103 (2006) 19290
51. Ugi S., Imamura T., Maegawa H., et al. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol Cell Biol 24 (2004) 8778
52. Zhao J.J., Gjoerup O.V., Subramanian R.R., et al. Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cell 3 (2003) 483
53. Yuan H., Veldman T., Rundell K., et al. Simian virus 40 small tumor antigen activates AKT and telomerase and induces anchorage-independent growth of human epithelial cells. J Virol 76 (2002) 10685